Chemical activators of ZNF772 can initiate a variety of intracellular signaling cascades that result in the functional activation of the protein. Phorbol 12-myristate 13-acetate (PMA) serves as an effective activator by mimicking diacylglycerol, which is a natural activator of protein kinase C (PKC). Once activated, PKC can phosphorylate target proteins, which may include ZNF772, thereby enhancing its activity. Similarly, Forskolin works by increasing intracellular cAMP levels, resulting in the activation of protein kinase A (PKA). PKA then can phosphorylate ZNF772, leading to activation. Ionomycin functions by escalating intracellular calcium levels, which activates calmodulin-dependent kinases (CaMK). The activation of CaMK can then result in the phosphorylation and subsequent activation of ZNF772. Thapsigargin contributes to the activation of ZNF772 by increasing cytosolic calcium concentration through the inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), indirectly leading to the activation of CaMK, which in turn can activate ZNF772.
In addition to these, Calyculin A and Okadaic Acid both act by inhibiting protein phosphatases, specifically PP1 and PP2A. This inhibition maintains various proteins, including potentially ZNF772, in a phosphorylated and active state. Anisomycin activates stress-activated protein kinases (SAPKs), which can lead to the phosphorylation and activation of ZNF772. Staurosporine, although known as a kinase inhibitor, can paradoxically activate kinase pathways under certain conditions, thereby leading to the activation of ZNF772 through phosphorylation. Dibutyryl-cAMP, a synthetic analogue of cAMP, activates PKA, which can then phosphorylate and activate ZNF772. H-89 might indirectly lead to the activation of kinases that phosphorylate ZNF772, despite its primary role as a PKA inhibitor. Epigallocatechin gallate (EGCG) interacts with various kinase pathways with the potential to phosphorylate and activate ZNF772. Lastly, Bisindolylmaleimide I, also known as a PKC inhibitor, can under specific conditions activate kinases that result in the phosphorylation and activation of ZNF772, demonstrating the complexity and interconnectivity of these signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate and thereby activate ZNF772 through downstream signaling cascades. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises cAMP levels, which in turn activates protein kinase A (PKA). PKA can then phosphorylate and activate ZNF772. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium concentration, leading to the activation of calmodulin-dependent kinases (CaMK), which can activate ZNF772. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin elevates cytosolic calcium by inhibiting SERCA, which indirectly activates CaMK, potentially leading to the activation of ZNF772. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A inhibits protein phosphatases, resulting in a sustained phosphorylated state of proteins, which could include the activation of ZNF772. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which may phosphorylate and activate ZNF772. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine can activate certain kinase pathways under specific conditions, leading to phosphorylation and activation of ZNF772. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a cAMP analogue that activates PKA, which in turn can phosphorylate and activate ZNF772. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $92.00 $182.00 | 71 | |
H-89, while primarily a PKA inhibitor, has off-target effects that may activate kinases responsible for ZNF772 phosphorylation and activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG interacts with multiple kinase pathways, potentially including those that phosphorylate and activate ZNF772. | ||||||